Activity of aromathecins against African trypanosomes

Nathaniel P. Nenortas, Maris A. Cinelli, Andrew E. Morrell, Mark Cushman, Theresa A. Shapiro

Research output: Contribution to journalArticlepeer-review

3 Scopus citations


African sleeping sickness is responsible for thousands of deaths annually, and new therapeutics are needed. This study evaluated aromathecins, experimental inhibitors of mammalian topoisomerase IB, against Trypanosoma brucei African trypanosomes. The compounds had selectively toxic antiparasitic potency, in situ poisoning activity against the phylogenetically unique topoisomerase in these parasites, and a representative compound intercalated into DNA with micromolar affinity. DNA intercalation and topoisomerase poisoning may contribute to the antitrypanosomal activity of aromathecins.

Original languageEnglish (US)
Article numbere00786-18
JournalAntimicrobial agents and chemotherapy
Issue number11
StatePublished - Nov 2018


  • Aromathecin
  • Sleeping sickness
  • Structure-activity
  • Topoisomerase
  • Trypanosoma brucei

ASJC Scopus subject areas

  • Pharmacology
  • Pharmacology (medical)
  • Infectious Diseases


Dive into the research topics of 'Activity of aromathecins against African trypanosomes'. Together they form a unique fingerprint.

Cite this